e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sleep-disordered breathing and hormones
Saaresranta T., Polo O.
Source:
Eur Respir J 2003; 22: 161-172
Journal Issue:
July
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Saaresranta T., Polo O.. Sleep-disordered breathing and hormones. Eur Respir J 2003; 22: 161-172
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep
Source: Eur Respir Rev 2007; 16: 115-124
Year: 2007
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Treatment of obstructive sleep-disordered breathing with positive airway pressure systems
Source: Eur Respir Rev 2007; 16: 125-131
Year: 2007
CPAP and measures of cardiovascular risk in males with OSAS
Source: Eur Respir J 2008; 32: 1488-1496
Year: 2008
Inspiratory duty cycle responses to flow limitation predict nocturnal hypoventilation
Source: Eur Respir J 2009; 33: 1068-1076
Year: 2009
Treatment options for central sleep apnea (including auto-CPAP)
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005
Obstructive sleep apnea
Source: Respipedia Article
Year: 2017
Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex
Source: Eur Respir J 2003; 21: 241-247
Year: 2003
Residual sleep-disordered breathing during autotitrating continuous positive airway pressure therapy
Source: Eur Respir J 2012; 39: 1391-1397
Year: 2012
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Source: Eur Respir J 2004; 23: 255-262
Year: 2004
Sleep, sleep-disordered breathing and metabolic consequences
Source: Eur Respir J 2009; 34: 243-260
Year: 2009
Sleep apnoea and systemic hypertension
Source: Eur Respir Mon 2010; 50: 150-173
Year: 2010
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2003; 22: 251-257
Year: 2003
Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Source: Eur Respir J 2009; 34: 694
Year: 2009
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Factors influencing the level of efficient pressure of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSAS)
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016
Continuous positive airway pressure treatment in patients with OSA
Source: Eur Respir Mon 2010; 50: 244-266
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept